Do you want to read an article? Please log in or register.
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer
Gastrointestinal Cancer
Indications
Related content
Gastrointestinal Cancer
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial
J Clin Oncol
Gögenur I, Justesen TF, Tarpgaard LS, Bulut M, Hansen TF, Jensen LH, Rahr HB, Gögenur M, Kirkegaard T, Balsevicius L, Chieng M, Raskov H, Sørensen MKS, Petersen PC, Eriksen JR, Salomon S, Fiehn AK, Mikkelsen MD, Brandsborg S, Gotschalck KA, Emmertsen KJ, Ramlov A, Born PW, Thorlacius-Ussing O, Lauritzen MB, Olesen RK, Poulsen LØ, Lykke J, Schou J, Buskov L, Krarup PM, Andersen CL, Pallisgaard N, Pfeiffer P, Qvortrup C
doi: 10.1200/JCO-25-02274
Gastrointestinal Cancer
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial
Lancet Gastroenterol Hepatol
Tarpgaard LS, Poulsen LØ, Gögenur I, Justesen TF, Rafaelsen SR, Øgaard N, Demuth C, Andersen CL, Ventzel L, Larsen PØ, Ramlov A, Ljungmann K, Lauritzen MB, Diness LV, Lykke J, de Lima VAB, Kjær S, Salomon S, Andersen PV, Pfeiffer P
doi: 10.1016/S2468-1253(26)00047-6
Gastrointestinal Cancer
Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4)
Eur J Cancer
Tashiro K, Osumi H, Kataoka K, Shimada Y, Inomata M, Hamaguchi T, Takii Y, Suwa Y, Mizusawa J, Sano Y, Suto T, Murata K, Adachi T, Ueno H, Ikeda S, Komori K, Shiozawa M, Tsukamoto S, Takashima A, Kanemitsu Y
doi: 10.1016/j.ejca.2026.116957
Gastrointestinal Cancer
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
Lancet
Hecht JR, Park YS, Tabernero J, Lee MA, Lee S, Virgili AC, Van den Eynde M, Fontana E, Fakih M, Asghari G, So J, Stein A, Dubreuil O, Bodnar L, He CS, Wang G, Smith R, Eng C, Saeed A, STELLAR-303 study investigators
doi: 10.1016/S0140-6736(25)02025-2
Gastrointestinal Cancer
Colon cancer with a peritumoural abscess: Real-world evidence on prognostic and therapeutic implications of a disregarded entity
Eur J Cancer
Rademaker E, van der Woude JM, van den Berg R, Brohet RM, Snaebjornsson P, de Hingh IHJT, Kok NFM, Consten ECJ, van Westreenen HL, Tanis PJ, collaborators of the Dutch Snapshot Research Group and Dutch Complex Colon Cancer Initiative
doi: 10.1016/j.ejca.2026.116705
Gastrointestinal Cancer
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Eur J Cancer
Lee PC, Cortellini A, Stefanini B, Yoo C, Chon HJ, Cheon J, Kudo M, Nishida N, Scheiner B, Pinter M, Lombardi P, Fulgenzi CAM, D'Alessio A, Brunetti L, Torkpour A, Valenzi E, Crowley F, Marron TU, Hsu WF, Celsa C, Cabibbo G, Cammà C, Galle PR, Vivaldi C, Masi G, Sharma R, Lin RP, Lin CY, Wietharn B, Saeed A, Tovoli F, Piscaglia F, Dalbeni A, Auriemma A, Sacerdoti D, Parisi A, Manfredi GF, Dondo A, Rimassa L, Pirisi M, Schönlein M, von Felden J, Singal AG, Parkih ND, Andanamala H, Ulahannan S, Roehlen N, Thimme R, Huang YH, Pinato DJ
doi: 10.1016/j.ejca.2026.116749
Gastrointestinal Cancer
Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trial
Lancet Gastroenterol Hepatol
Tuynman JB, Yao H, Moolenaar LR, Sietses C, Hompes R, Aigner F, Caycedo-Marulanda A, Chen CC, Deeb M, Doornebosch PG, Feng B, Foo CC, Fürst A, Ito M, de Lacy FB, Leão P, Maykel JA, Muratore A, van Oostendorp SE, Park SC, Pędziwiatr M, Ren M, Seitinger G, Stockmann HBAC, Talsma AK, Türler A, Tong W, Wang Q, Xu Q, Zhang H, van Waesberghe JTM, Ali M, Twisk JWR, Zhang Z, de Lacy AM, Hanna GB, Bonjer HJ, COLOR III Study Group
doi: 10.1016/S2468-1253(26)00022-1
Gastrointestinal Cancer
World Cancer Research Fund /American Institute for Cancer Research Screener algorithm versus standard Score: Association with mortality in colorectal cancer patients
Cancer Epidemiol Biomarkers Prev
Nafría M, Wesselink E, Kampman E, van Zutphen M, van Duijnhoven FJB, Kok DE, Romaguera D, Winkels RM
doi: 10.1158/1055-9965.EPI-25-2056
Gastrointestinal Cancer
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
Eur J Cancer
Casadei-Gardini A, Yip TC, Vitale A, Rossari F, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Piscaglia F, Kumada T, Scartozzi M, Tamburini E, Foschi FG, Camera S, Persano M, Pia D'Agata A, Ferrara M, Passeri L, Rimassa L, Rimini M
doi: 10.1016/j.ejca.2026.116750